ROSWELL, N.M. (AP) -- A New Mexico health clinic has confirmed that some patients may have received possibly tainted anti-inflammatory injections prepared by a compounding manufacturer in Tennessee.
The Roswell Daily Record reports (http://bit.ly/18B5rbY) that Roswell Family Care said this week that around 50 patients received an injectable steroid involved in a U.S. Food and Drug Administration investigation.
Methylprednisolone acetate (MPA) is used to treat inflammation, asthma, joint and upper respiratory issues. It is suspected of killing at least 55 people last year following an outbreak of fungal meningitis.
The Roswell clinic's nurse practitioner David Aguilar says so far there are no cases of infection or reactions in New Mexico.
Main Street Family Pharmacy of Newbern, Tenn. shipped the tainted medicine to clinics in 13 states.
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to firstname.lastname@example.org. Please provide detailed information.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.